Envista-backed Nobel Biocare, a company that manufactures dental implants and CAD/CAM-based individualized prosthetics, agreed to acquire Osteogenics Biomedical, a company in the development of innovative dental bone grafting products serving Periodontists. Financial terms were not disclosed. "Increasing our capabilities in regenerative solutions is consistent with our intention to digitize, personalize, and democratize oral care. Osteogenics is a recognized pioneer in membrane technologies used in dental bone grafting procedures. They are a trusted brand and have a proven track record of growth. We are excited to welcome the Osteogenics team to Envista," Amir Aghdaei, Envista CEO.